Published in Health Business Week, June 11th, 2004
"We are delighted that our investors have confirmed their confidence in AmpliMed and its clinical development programs, enabling us to successfully complete our first significant round of financing," noted Robert A. Ashley, chairman, CEO and president of AmpliMed.
"This funding will enable us...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.